Phase II Study of Irinotecan and Cetuximab Given Every 2 Weeks as Second-Line Therapy for Advanced Colorectal Cancer

✍ Scribed by Benedito A. Carneiro; Ramesh K. Ramanathan; Marwan G. Fakih; Smitha S. Krishnamurthi; Barry C. Lembersky; Ronald G. Stoller; Stewart L. Lancaster; Richard A. Pinkerton; Theodore L. Crandall; Amy R. Schmotzer; Douglas M. Potter; Nathan Bahary

• Book ID: 116365623
• Publisher: CIG Media Group, LP.
• Year: 2012
• Tongue: English
• Weight: 359 KB
• Volume: 11
• Category: Article
• ISSN: 1533-0028
• DOI: 10.1016/j.clcc.2011.05.003